Clinical Research Jobs in Menlo Park, CA
Please select the country where you want to search for a job.
-
Job Type
-
Posting Date
12 Jobs Found | Sort By : Relevance | Posted Date
Less results matching your search!
Try removing some of the filters to get more results
No results matching your search!
Try removing some of the filters to get more results
Site Contracts Associate
Summit Therapeutics Sub
Menlo Park - USA
Location:On-site 4 days per week at our Menlo Park CA Princeton NJ or Miami FL locationsAbout SummitIvonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects asso...
Senior Director, Clinical Operations (tmf & Ctms)
Summit Therapeutics Sub
Menlo Park - USA
Location: On-site 4 days per week at our Menlo Park CA Princeton NJ or Miami FL office.About Summit: Ivonescimab also known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effect...
Senior Director, Regulatory Affairs Global Regulat...
Summit Therapeutics Sub
Menlo Park - USA
Location: Palo Alto CA / Miami FL / Princeton NJ onsiteAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a...
Senior Manager, Procurement & Vendor Management (r...
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Central Monitoring Associate (cma)
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Executive Director, Biostatistics
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Director, Corporate Development
Hello Heart
Menlo Park - USA
About Hello Heart:Hello Heart is on a mission to change the way people care for their hearts. The company provides the first app and connected heart monitor to help people track and manage their heart health. With Hello Heart users take steps to control their risk of heart attacks and stroke the le...
Clinical Research Psychology Technician
Pavir
Menlo Park - USA
Palo Alto Veterans Institute for Research (PAVIR) supports the nations second largest research program conducted among the VA Hospitals and is looking for a temporary part-time Clinical Research Psychology Technician who will support Principal Investigator Dr. Eric Kuhn.The Life Sciences Psychology...
Manager, Clinical Study Start Up
Summit Therapeutics Sub
Menlo Park - USA
Location: On-Site 4 days per week at our Menlo Park CA officeAbout Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF...
Director, Clinical Scientist
Summit Therapeutics Sub
Menlo Park - USA
About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperati...
Clinical Research Associate Ii
Summit Therapeutics Sub
Menlo Park - USA
Location: On-Site 4 days per week at ourMenlo Park CA Princeton NJ or Miami FL office.About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects assoc...
Clinical Research Associate Ii
Summit Therapeutics Sub
Menlo Park - USA
Location: On-Site 4 days per week at our Menlo Park CA Princeton NJ or Miami FL office.About Summit:Ivonescimab known as SMT112 is a novel potential first-in-class investigationalbispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects ass...
